usden

Development and assessment of a population-based Proton Pump Inhibitor deprescribing intervention

June 9, 2026 at 2PM ET | 11AM PT Presenter: Dr. Jean-Pascal Fournier Description: Population-based deprescribing interventions are needed to reach large and unselected populations. During this webinar, we presented the development of the DeprescrIPP intervention, which involved a patient- and general practitioner -facing intervention at the healthcare system-scale. Then, we presented the result of the study […]

Development and assessment of a population-based Proton Pump Inhibitor deprescribing intervention Read More »

The Patient Evaluation of the Deprescribing Process Questionnaire (PED-Q): A new tool for practice and trials

March 3, 2026 at 2PM ET | 11AM PT Presenter: Dr. Sion Scott, Associate Professor of Behavioural and Implementation Sciences, School of Health Sciences, University of East Anglia Description: There is a gap between older adults’ theoretical willingness to stop unnecessary medicines and their acceptance of deprescribing in trials. To improve deprescribing uptake, we need to identify which

The Patient Evaluation of the Deprescribing Process Questionnaire (PED-Q): A new tool for practice and trials Read More »

Contribution of the RETREAT FRAIL study to the deprescribing of antihypertensive treatments in very old subjects

December 2, 2025 at 2PM ET | 11AM PT Presenter: Professor Athanase Benetos, MD, PhD Description:This webinar 1) presented the role of frailty in the management of hypertension in older adults 2) Describe the rationale, protocol, and main results of the Retreat-Frail randomized clinical trial, and 3) Discuss the impact of the results of this trial

Contribution of the RETREAT FRAIL study to the deprescribing of antihypertensive treatments in very old subjects Read More »

Diabetes Deprescribing in Older Adults: Academic Detailing and Patient Pre-Visit Activation

September 30, 2025 at 2PM ET | 11AM PT Presenter(s): Dr. Richard Grant Description:Iatrogenic hypoglycemia has become the leading preventable treatment complication in older adults with type 2 diabetes. In this context, deprescribing requires informed collaboration and decision-making between patients and providers. This webinar focused on the implementation and results of academic detailing and patient pre-visit

Diabetes Deprescribing in Older Adults: Academic Detailing and Patient Pre-Visit Activation Read More »

USDeN-Funded Pilot Award Application Information Session (2026-2027 Cycle)

August 26, 2025   |  2:00 – 3:00 PM Eastern / 11:00 – 12:00 PM Pacific Presenter(s): Drs. Amanda Mixon & Sandra Simmons Description: This webinar covered the details of the application preparation and submission process for USDeN-Funded Pilot Awards for the 2026-2027 cycle. DOWNLOAD PRESENTATION POWERPOINT (PDF) »​

USDeN-Funded Pilot Award Application Information Session (2026-2027 Cycle) Read More »

Slow and Patient Centered: A new Clinical Practice Guideline on Benzodiazepine Tapering

June 24, 2025 at 2PM ET | 11AM PT Presenter(s): Drs. Maureen Boyle & Donovan Maust Description: Benzodiazepines are critical medications, but they are often overused and challenging to discontinue. Ten medical and professional societies collaborated to develop the new Joint Clinical Practice Guideline on Benzodiazepine Tapering, which aims to help clinicians in diverse practice

Slow and Patient Centered: A new Clinical Practice Guideline on Benzodiazepine Tapering Read More »

Personalized Medication Deprescribing for Older Adults: Leveraging AI and Building Trust in AI-Driven Clinical Guidance.

March 4, 2025 at 2PM ET | 11AM PT Presenter: Dr. Juliessa Pavon Description: This webinar highlighted an innovative approach to personalized medication deprescribing, using causal inference and AI/machine learning techniques to analyze multi-site EHR and Medicare claims data. It focused on developing AI-based individualized treatment rules to provide clinicians with tailored recommendations for medication

Personalized Medication Deprescribing for Older Adults: Leveraging AI and Building Trust in AI-Driven Clinical Guidance. Read More »

Research and Implementation on Deprescribing from the VA Center for Medication Safety in Aging

February 4, 2025 at 2PM ET | 11AM PT Presenter(s): Drs. Ken Boockvar & Amy Linsky Description: The VA Center for Medication Safety in Aging aims to 1) promote the development of novel deprescribing interventions and evaluate their impact on outcomes important to Veterans and providers, and 2) facilitate implementation of deprescribing interventions across VA. Learn

Research and Implementation on Deprescribing from the VA Center for Medication Safety in Aging Read More »

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.